CAR‐T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment - Abecassis, Audrey; Roders, Nathalie; Fayon, Maxime; Choisy, Caroline; Nelson, Elisabeth; Harel, Stephanie; Royer, Bruno; Villesuzanne, Camille; Talbot, Alexis; Garrick, David; Goodhardt, Michele; Fermand, Jean‐Paul; et al. (EJHaem, 2022)
Keywords: Antigens; CAR‐T cells; Chimeric antigen receptors; Cytotoxicity; daratumumab; Diagnosis; Immunological memory; Lymphocytes; Lymphocytes T; Memory cells; Multiple myeloma; Patients; Peripheral blood; peripheral tcells; Phenotypes; Ratios; relapse; Short Report; Short Reports; peripheral tcells; multiple myeloma; CAR‐T cells; daratumumab; relapse